Evidence map›Paper›PMID 33001861›Full record

ArticleJCI insight2020

Conditional Myh9 and Myh10 inactivation in adult mouse renal epithelium results in progressive kidney disease.

Karla L Otterpohl, Brook W Busselman, Ishara Ratnayake, Ryan G Hart, Kimberly R Hart, Claire M Evans, Carrie L Phillips, Jordan R Beach, Phil Ahrenkiel, Bruce A Molitoris and 2 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Insights into Uromodulin and Blood Pressure.Current hypertension reports · 2024
    Review
  9. Review
  10. Article
  11. Actin cytoskeleton and associated myosin motors within the renal epithelium.American journal of physiology. Renal physiology · 2024
    Review
  12. Article
  13. Article
  14. Role of Uromodulin in Salt-Sensitive Hypertension.Hypertension (Dallas, Tex. : 1979) · 2022
    Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Karla L OtterpohlEnabling Technologies Group, Sanford Research, Sioux Falls, South Dakota, USA.
Brook W BusselmanEnabling Technologies Group, Sanford Research, Sioux Falls, South Dakota, USA.
Ishara RatnayakeDepartment of Nanoscience and Nanoengineering, South Dakota School of Mines and Technology, Rapid City, South Dakota, USA.
Ryan G HartEnabling Technologies Group, Sanford Research, Sioux Falls, South Dakota, USA.
Kimberly R HartDepartment of Pediatrics, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota, USA.
Claire M EvansHistology and Imaging Core, Sanford Research, Sioux Falls, South Dakota, USA.
Carrie L PhillipsDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Jordan R BeachDepartment of Cell and Molecular Physiology, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois, USA.
Phil AhrenkielDepartment of Nanoscience and Nanoengineering, South Dakota School of Mines and Technology, Rapid City, South Dakota, USA.
Bruce A MolitorisDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Kameswaran SurendranDepartment of Pediatrics, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota, USA.
Indra ChandrasekarEnabling Technologies Group, Sanford Research, Sioux Falls, South Dakota, USA.
University of South Dakota · USSanford Research · USIndiana University School of MedicineSouth Dakota School of Mines and Technology · USLoyola University Chicago · US

Funding

Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Molecular Regulators of Renal Collecting Duct Differentiation and MaintenanceR01DK106135 · NIDDK · SANFORD RESEARCH/USD · PI SURENDRAN, KAMESWARAN · 2016 to 2019
$1.5M
NIDDK NIH HHS R01 DK106135NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620
6 · The paper itself

Abstract

Actin-associated nonmuscle myosin II (NM2) motor proteins play critical roles in a myriad of cellular functions, including endocytosis and organelle transport pathways. Cell type-specific expression and unique subcellular localization of the NM2 proteins, encoded by the Myh9 and Myh10 genes, in the mouse kidney tubules led us to hypothesize that these proteins have specialized functional roles within the renal epithelium. Inducible conditional knockout (cKO) of Myh9 and Myh10 in the renal tubules of adult mice resulted in progressive kidney disease. Prior to overt renal tubular injury, we observed intracellular accumulation of the glycosylphosphatidylinositol-anchored protein uromodulin (UMOD) and gradual loss of Na+ K+ 2Cl- cotransporter from the apical membrane of the thick ascending limb epithelia. The UMOD accumulation coincided with expansion of endoplasmic reticulum (ER) tubules and activation of ER stress and unfolded protein response pathways in Myh9&10-cKO kidneys. We conclude that NM2 proteins are required for localization and transport of UMOD and loss of function results in accumulation of UMOD and ER stress-mediated progressive renal tubulointerstitial disease. These observations establish cell type-specific role(s) for NM2 proteins in regulation of specialized renal epithelial transport pathways and reveal the possibility that human kidney disease associated with MYH9 mutations could be of renal epithelial origin.

Indexed as

Endoplasmic Reticulum StressAnimalsEpitheliumFemaleKidney DiseasesKidney TubulesMaleMiceMice, Inbred C57BLMice, KnockoutMyosin Heavy ChainsMyosin Type IINonmuscle Myosin Type IIBPodocytesSolute Carrier Family 12, Member 1Unfolded Protein ResponseMyh9 protein, mouseMyosin Heavy ChainsMyosin Type IINonmuscle Myosin Type IIBnonmuscle myosin type IIB heavy chainSlc12a1 protein, mouseSolute Carrier Family 12, Member 1UromodulinCell BiologyChronic kidney diseaseCytoskeletonMolecular geneticsNephrology

Identifiers

PMID33001861
PMCPMC7710296
OpenAlexW3090287310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.